Huong Huynh
Nurse Practitioner · Tulsa, OKNPI 1255564589
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 525 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 525 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Dexcom, Inc.$1K
- Abbott$916
- Novo Nordisk$711
- Tandem Diabetes Care, Inc.$501
- Bayer$493
- plus $5K from 29 others
What the payments were for
- Food & beverage$9,784100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 60 | $1,213 |
| Dexcom, Inc. | 84 | $1,174 |
| Abbott | 52 | $916 |
| Novo Nordisk | 50 | $711 |
| Tandem Diabetes Care, Inc. | 17 | $501 |
| Bayer | 28 | $493 |
| Novartis | 27 | $449 |
| Boehringer Ingelheim | 26 | $448 |
| Esperion Therapeutics, Inc. | 16 | $409 |
| Amgen | 27 | $399 |
| Insulet Corporation | 10 | $392 |
| Medtronic | 4 | $298 |
| Corcept Therapeutics | 17 | $289 |
| Amneal Pharmaceuticals LLC | 14 | $281 |
| Xeris Pharmaceuticals, Inc. | 13 | $253 |
| Mannkind Corporation | 14 | $225 |
| AbbVie | 13 | $220 |
| AstraZeneca(2 entities) | 6 | $177 |
| Currax Pharmaceuticals LLC | 9 | $135 |
| Intra-sana Laboratories | 5 | $116 |
| Johnson & Johnson | 2 | $101 |
| Kyowa Kirin, Inc. | 4 | $82 |
| Recordati_rare_diseases_inc. | 3 | $76 |
| BETA Bionics, Inc. | 3 | $70 |
| Astellas Pharma US Inc | 2 | $61 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| Antares Pharma, Inc. | 3 | $52 |
| Endo Pharmaceuticals Inc. | 3 | $42 |
| Halozyme Inc | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Sequel Med Tech, LLC | 1 | $23 |
| Zealand Pharma US, Inc. | 1 | $20 |
| Ascendis Pharma Endocrinology Inc | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIMPLERA SENSOR$155
- NEXLIZET$119
- NEXLETOL$119
- t:slim X2 Insulin Pump with Control-IQ$119
- MINIMED 780G$110
- JARDIANCE$110
- ZEPBOUND$109
- Omnipod$108
How this compares
$9,795 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StrensiqAsfotase Alfa | 15 | $3,035,051 |
| OzempicSemaglutide | 634 | $838,231 |
| MounjaroTirzepatide | 347 | $436,748 |
| JardianceEmpagliflozin | 317 | $363,073 |
| Tresiba Flextouch U-200Insulin Degludec | 165 | $274,980 |
| TrulicityDulaglutide | 171 | $246,243 |
| FarxigaDapagliflozin Propanediol | 118 | $135,988 |
| Humalog Kwikpen U-200Insulin Lispro | 36 | $102,292 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 43 | $94,478 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 69 | $88,035 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 65 | $77,604 |
| Tresiba Flextouch U-100Insulin Degludec | 74 | $70,457 |
| TradjentaLinagliptin | 78 | $64,433 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 60 | $63,475 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 67 | $53,500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaStrensiq, Farxiga | $177 | $3,171,039133 claims |
| Novo NordiskOzempic, Novolog, Rybelsus | $711 | $889,397712 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,213 | $697,166564 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Glyxambi | $448 | $501,360469 claims |
| BayerKerendia | $493 | $46,93847 claims |
| MerckJanumet Xr, Januvia | $13 | $41,75553 claims |
| AmgenProlia | $399 | $26,70515 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $27 | $13,58421 claims |
| AbbVieSynthroid | $220 | $12,591140 claims |
| Esperion Therapeutics, Inc.Nexlizet | $409 | $11,18927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Other nurse practitioner in Tulsa
- Jenny GuthrieTulsa$106K
- Stacy NewberryTulsa$28K
- Amanda SmallTulsa$14K
- Mindi PriceTulsa$11K
- Jonathan BouldinTulsa$10K
- Michelle LoeberTulsa$10K
- Erin WilliamsonTulsa$9K
- Andrea CarpenterTulsa$7K
- Charles SpradlinTulsa$7K
- Leslie BurtonTulsa$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.